The administrative burdens plaguing medical practices – from billing and insurance verification to supply chain management – are a well-known source of frustration for physicians. Now, a Harvard University dropout turned entrepreneur is aiming to alleviate those pain points with a new approach powered by artificial intelligence. Nitra, a healthcare financial and operational platform founded by Tim Hwang, recently announced a $50 million Series B funding round, bringing its total funding to $205 million according to Fortune.
Hwang’s path to healthcare innovation is unconventional. After working on Barack Obama’s 2008 presidential campaign and studying public policy at Princeton University, he founded FiscalNote, a company he took public before the age of 30. Nitra, however, represents what he calls “the perfect confluence of everything I’ve worked on in the past,” tackling a sector ripe for disruption.
Nitra distinguishes itself by offering an AI-native operating platform designed specifically for medical practices. Unlike the patchwork of separate software systems currently used for tasks like billing, purchasing, and scheduling, Nitra consolidates these functions into a single, AI-powered system. The company’s goal is to automate the entire back-office operation, from expense management and accounting to patient communications and claims filing.
A Credit Card as a Gateway to Efficiency
Nitra’s entry point into a medical practice is surprisingly simple: a credit card. Designed for physicians, the card is linked to a comprehensive backend suite that handles expense management, accounting integration, inventory management, and procurement. Hwang describes this approach as a “Trojan horse,” allowing Nitra to gather data and build trust with practices. As doctors use the card for purchases – medical equipment, surgical supplies – Nitra categorizes their spending and provides detailed accounting information.
This initial engagement expands into a broader marketplace, Nitra Rx and Nitra Mart, where doctors can directly purchase pharmaceuticals and specialty equipment. AI agents then orchestrate the administrative tasks associated with these purchases, including account reconciliation, insurance claim filing, scheduling, benefits verification, and patient communications. “We start very small with the doctor, build trust, get them on the card, get them on our bill pay, get them our accounting system, have them start ordering equipment from us, and then we start orchestrating all of that kind of back-office administrative operate using our agents,” Hwang explained.
Rapid Growth and Expansion
As of December 2025, Nitra’s platform has processed over $1 billion in annualized transactions and generated $33 million in annual recurring revenue, representing an eight-fold increase year-over-year. More than 700 clinics are currently utilizing the platform. Hwang anticipates continued rapid growth, stating, “I think we’re probably in the first inning of our growth trajectory,” and expressing confidence in reaching $1 billion in revenue within the next few years.
The company’s growth is being fueled, in part, by pressures on the healthcare supply chain. Fluctuations in the cost of essential supplies, like surgical gloves and syringes, are prompting practices to seek better cost control measures. Physicians are becoming more comfortable with AI-powered tools, extending their acceptance beyond clinical applications to administrative tasks.
Industry Veteran Joins Nitra’s Board
To further bolster its position, Nitra has added Dr. Richard Park, founder of CityMD and former executive at Summit Health+CityMD, to its board of directors. Hwang lauded Park as “a legend in the healthcare space” and a valuable connection to physician entrepreneurs. Park’s experience building CityMD, a prominent urgent care chain, is expected to provide valuable insights as Nitra expands its reach.
Hwang’s interest in healthcare stems from witnessing the complexities of the system firsthand during his time working on the Affordable Care Act and, more acutely, during the COVID-19 pandemic. The strain on the healthcare system during the pandemic highlighted the existing inefficiencies and prompted him and co-founder Jonathan Chen to embark on a long-term project to address these challenges. Healthcare, as the largest employer in the United States and a significant household expense for many Americans, presented a compelling opportunity for innovation.
“If we can unlock 10 to 20% more time for doctors across the country, that would be a tremendous impact on society,” Hwang said. He believes Nitra has the potential to become a “decacorn” – a privately held company valued at over $10 billion.
Disclaimer: This article provides informational content only and should not be considered medical or financial advice. Consult with a qualified professional for personalized guidance.
The future of healthcare administration is rapidly evolving. Nitra’s success will depend on its ability to continue scaling its platform, integrating new technologies, and adapting to the changing needs of medical practices. What remains clear is that the demand for streamlined, efficient solutions in healthcare is substantial, and Nitra is positioning itself to be a key player in this transformation. Share your thoughts on the future of healthcare technology in the comments below.
